Drug Report History #172389
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v22-FR | Version v6-FR |
|---|---|---|
| Language | French | French |
| Date Updated | 2023-02-02 (Updated) | 2022-11-21 |
| Drug Identification Number | 00022799 | 00022799 |
| Brand name | ZARONTIN CAP 250MG | ZARONTIN CAP 250MG |
| Common or Proper name | ZARONTIN CAP | ZARONTIN CAP |
| Company Name | ERFA CANADA 2012 INC | ERFA CANADA 2012 INC |
| Ingredients | ETHOSUXIMIDE | ETHOSUXIMIDE |
| Strength(s) | 250MG | 250MG |
| Dosage form(s) | CAPSULE | CAPSULE |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | BOTTLE 100'S | BOTTLE 100'S |
| ATC code | N03AD | N03AD |
| ATC description | ANTIEPILEPTICS | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-10-06 | 2022-10-06 |
| Actual start date | 2022-10-07 | 2022-10-07 |
| Estimated end date | 2023-02-15 (Updated) | 2022-11-30 |
| Actual end date | 2023-02-01 (Updated) | |
| Shortage status | Resolved (Updated) | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | RESOLVED (Updated) | |
| Health Canada comments |